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Abstract
Abstract: Malignant mental neuropathy (MMN) is a neurological manifestation of cancer, characterized by the 
presence of hypoesthesia or anesthesia restricted to the territory of the mental branch of the mandibular nerve. A 
systematic review of the literature has been made on MMN, analyzing the etiology, pathogeny, clinical characteristics, 
complementary tests and the prognosis. Sixteen studies, providing 136 cases were selected. Breast cancer and lympho-
mas were the most frequently associated malignant diseases. The most frequent pathogenic mechanisms producing 
neurological involvement were: peripherally, mandibular lesions; and centrally, tumors at the base of the cranium. 
Regarding clinical characteristics, manifestation of MMN was the primary symptom of malignant disease in 27.7% 
of cases, and a first symptom of recurrence in 37.7%. The group of selected studies included 50 orthopantomographs, 
9 mandibular computed tomographies and 50 radiographic examinations of the cranial region. The most affected 
region was the mandible. The appearance of MMN is an ominous prognosis for the progression of the disease, with 
a mortality of 78.5% within a mean of 6.9 months.
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Introduction
Malignant mental neuropathy (MMN) is a neurological 
manifestation of cancer, characterized by numbness in 
the region innervated by the mental nerve: skin of the 
chin, oral mucosa and lower lip of the affected hemis-
phere (1).
According to Massey et al. (2) in 47% of cases it is the 
first clinical manifestation of  malignant disease or its 
recurrence. Its appearance is associated with an ominous 
prognosis (3). Numb chin often goes unnoticed, and may 
indicate tumor metastasis (1). The first article on MMN 
was published in 1963 by Calverley and Mohnac (4) who 
presented three patients and introduced the term ‘numb 
chin syndrome’. The literature on MMN is wide in clinical 
series with few patients and descriptions of isolated cases; 
the study with most patients published to date was made 
in 2002 by Lossos and Siegal (3) with 42 cases.
The aim of this systematic review on MMN is to study 
the etiology, the pathogeny, the clinical characteristics, 
complementary tests and prognosis.
Search strategy and inclusion criteria
A search in PubMed was made of all studies published on 
MMN to November 2007. The following key words were 
used: ‘numb chin syndrome’ for which 51 references were 
found, ‘mental nerve neuropathy’ with 198, and ‘mental 
numbness’ with 148. Inclusion criteria were articles publis-
hed on MMN with three or more patients and a minimum 
Publication Types: Review
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follow-up of one year, providing sixteen studies with a 
total of 136 cases (1-16).
Etiology
MMN is associated with different types of cancer. Of the 
136 cases analyzed, the most frequent primary malignant 
disease was breast cancer in 40.4% of cases, followed by 
lymphomas in 20.5%, prostate cancer in 6.6% and leuke-
mia in 5.1%. The remainder of the cases were constituted 
by a miscellany of lesions (Table 1).
Pathogeny
The mechanisms by which MMN is produced are not well 
known, and different hypotheses have been proposed. 
The origin may be peripheral or central (6). Peripherally, 
mandibular bone tumors, with direct nerve infiltration, 
were the most frequent original neoplasm, being found 
in 50% of cases (3,13,15). Centrally, the most frequent 
were tumors located at the base of the skull; these lesions 
may cause bone destruction or infiltration of the lepto-
meninges, close to the gasserian ganglion region (3). For 
Lossos and Siegal (3) MMN is produced by bone lesions 
at the base of the skull in 14% of cases, and in 22% by 
isolated leptomeningeal seeding. Other authors also find 
leptomeningeal involvement: Horton et al. (8) contributed 
13 patients with breast cancer and MMN, 5 of whom died, 
leptomeningeal carcinomatosis was found in the autopsy 
of all these cases. Rubinstein (7) presented 4 patients with 
non-Hodgkin's lymphoma and MMN, finding invasion of 
the meninges and the cranial nerve branches in the post-
mortem examination.
Occasionally, no relationship between MMN and a distant 
neoplasia can be determined (1). According to Pascual 
et al. (9) there is no single pathogeny that can explain all 
cases. For Lossos and Siegal (3), the cause was unknown 
in 11% of patients. Massey et al. (2) found no determinant 
cause for MMN in a series of 19 patients.
Clinical characteristics
MMN is characterized by numbness confined to the 
chin and lower lip, which is the consequence of loss of 
function of the terminal sensory division of the mandi-
bular branch of the trigeminal nerve; as a result of this 
lack of sensitivity, lesions caused by biting of the lower 
lip can be found (1, 5).
The following characteristics were analyzed in the 16 
selected articles (1-16): the age and sex of the patients, 
the location of  the symptom (unilateral/bilateral), the 
frequency of associated pain, the percentage in which the 
appearance was the first sign of malignant disease and as 
the first sign of relapse (Table 2).
The weighted mean age of the patients was 47.8 years; 
there were 81 females and 55 males. The affected side 
was specified in 117 patients of the entire sample, being 
unilateral in 97, and bilateral in 20. Lossos and Siegal (3), 
in 1992, found 10% with bilateral involvement, against 
14.7% in the present review. Of the 20 patients with bi-
lateral involvement, the primary malignant disease was 
determined in 16 (Table 2).
Pain is an infrequent symptom in MMN (1,2,8). Neuro-
genic pain was associated with MMN in 10 of the 136 
patients. According to Calvin et al. (17), tumor compres-
sion of the sensory trigeminal roots causes demineralized 
areas which would be the cause of pain.
The appearance of  MMN may be warning sign of  a 
systemic cancer or of its recurrence (7). Massey et al. (2) 
detected MMN prior to the diagnosis of cancer in 47% 
of 19 patients. For Vadell et al., MMN was the first sign 
of neoplastic relapse in 100% of their patients (11). In the 
present review, MMN appears as the primary manifesta-
tion of disease in 27.7% of cases and is the first symptom 
of a tumor recurrence in 37.7%.
Diagnosis and complementary tests
Against the appearance of mental neuropathy, the presen-
ce of a malignant or benign lesion should be investigated 
along the trigeminal nerve (11,12). A clinical examina-
tion is not sufficient to locate a lesion (16), therefore the 
appearance of a mental neuropathy obliges a complete 
radiographic examination of the trigeminal nerve (10).
Mandibular lesions were found in 51 cases, cerebral in 16, 
consisting of meningeal carcinomatosis, the base of the 
skull was involved in 15 patients, and in 47 the location of 
the lesion could not be determined (Table 3).
In the articles studied, orthopantomographs were made 
in 50 of 130 cases, with positive findings in 17; 50 exa-
minations of the cranial region were requested (cranial 
computed tomography, cranial radiography, or MRI of 
the brain) finding lesions in 30 cases. Out of 9 mandibular 
computed tomographies, lesions were found in 3 patients 
(Table 3).
Prognosis
MMN in patients with neoplasia may indicate recurrence 
of the tumor, and is associated with an ominous prognosis. 
In the sixteen studies reviewed, a mortality of 78.5% (66 
of 84 patients) was found, with a weighted mean survival 
of 6.9 months (Table 4).
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AUTHOR
Nº 
Patients
Location Orthopantomography
CT 
mandibular
CT or cranial X-ray / 
MRI cerebral
C BC M U Total + - Total + - Total + -
1963 Calverley and 
Mohnac4 
5 - - 3 2 5 1 4 - - - 1 1 0
1965 Rozman and Erill 5 5 - - 3 2 3 2 1 - - - 5 3 2
1969 Nobler 6 8 - - 3 5 - - - - - - 1 1 0
1969 Rubinstein 7 4 4 - - - - - - - - - 4 1 3
1973 Horton et al8 15 1 4 2 8 8 2 6 - - - 15 8 7
1981 Massey et al2 19 - - 5 14 12 4 8 - - - 2 0 2
1985 Barret10 4 - - - 4 1 1 0 - - - - - -
1986 Pascual et al9 3 - 1 1 1 3 1 2 - - - 1 1 0
1989  Vadell et al11 5 - - 4 1 5 0 5 - - - 3 1 2
1990 Peñarrocha et al12 3 - 1 1 1 3 0 3 - - - 2 1 1
1992 Burt RK et al13 4 - - 1 3 - - - - - - 4 2 2
1992 Lossos and Siegal3 36* 8 5 18 4 - - - - - - - - -
1997 Hiraki et al14 3 - - 3 - 3 3 0 - - - - - -
1999 Ojanguren et al15 4 - - 4 - - - - - - - 4 4 0
2000 Laurencet et al1 5 1 3 - 1 - - - 3 0 3 4 4 0
2006 Peñarrocha et al16 7 2 1 3 1 7 3 4 6 3 3 4 3 1
TOTAL 130 16 15 51 47 50 17 33 9 3 6 50 30 20
AUTHOR Nº Patients Mortality Weighted mean in months
1963 Calverley and Mohnac4 5 4 13
1965 Rozman and Erill 5 5 1 2
1969 Nobler 6 8 6 4
1969 Rubinstein 7 4 4 16
1973 Horton et al8 15 13 5
1981 Massey et al2 19 16 5
1985 Barret10 4 3 2
1986 Pascual et al9 3 3 6
1989  Vadell et al11 5 2 22
1990 Peñarrocha et al12 3 2 2
1992 Burt RK et al13 4 - -
1992 Lossos and Siegal3 36* - 8
1997 Hiraki et al14 3 0 0
1999 Ojanguren et al15 4 4 5
2000 Laurencet et al1 5 3 10
2006 Peñarrocha et al16 6** 5 9.8
TOTAL 129 66 of the patients 6.9¥
Table 3. Complementary tests.
Nº: number
*of the 42 patients, 6 were excluded for lack of follow-up
C: Cerebral. BC: Base of cranium M: Mandibular. U: Unknown
+ or -: lesion detected or lesion not detected
Table 4. Prognosis.
* of the 42 patients, 6 were excluded for lack of follow-up
** of the 7 patients one was lost to follow-up after 8 months
¥  weighted mean in months 
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